PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1443380
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1443380
Cell Expansion Market size was valued at USD 18,130.62 Million in 2023, expanding at a CAGR of 13.2% from 2024 to 2032.
Cell expansion is the process through which cells enlarge in size and volume, a critical phenomenon for the growth and development of organisms. This plays a pivotal role in various biological processes, including tissue formation, organ development, and overall body growth. In multicellular organisms, tight regulation of cell expansion is essential to maintain proper structural integrity and functionality. This process involves the absorption of water and solutes, leading to increased turgor pressure within the cell, resulting in expansion.
Cell Expansion Market- Market Dynamics
Increasing use of automated solutions to propel market demand
The global cell expansion market is experiencing growth due to the increasing use of automated solutions. These systems reduce manpower and costs associated with the creation of Cell Therapy Products (CTP), gene therapies, and other biologics, ensuring robust and reliable processes. The shift toward Single-Use Systems (SUS) in CTP manufacturing provides substantial production advantages by eliminating concerns about cross-contamination and culture contamination. SUS also enables the production of CTP with high cell densities, offering long-term cost savings. The adoption of SUS promotes the development of CTP, thereby stimulating market growth. In CTP manufacturing, the substitution of serum and other incompatible reagents is crucial for controlling product quality. Research studies have validated the use of serum-free media in ensuring product quality. Additionally, an optimization platform integrating high-throughput tools with a differential evolution-based algorithm has been developed as an automated and effective optimization strategy for serum-free culture formulations. In the third quarter of 2022, Lonza received commercial support for its two cell and gene therapies, SKYSONA and ZYNTEGLO.
Cell Expansion Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 13.2% over the forecast period (2024-2032)
Based on product type segmentation, consumables was predicted to show maximum market share in the year 2023
Based on cell type segmentation, mammalian was the leading type in 2023
Based on end user segmentation, biopharmaceutical & biotechnology companies was the leading type in 2023
On the basis of region, North America was the leading revenue generator in 2023
The Global Cell Expansion Market is segmented on the basis of Product Type, Application, Cell type, End user, and Region.
The market is divided into three categories based on product type: Consumables, Culture Flasks and Accessories and Instruments. In 2023, consumables led the product segment of the total market share. This segment is expected to maintain its dominant position in the forecast years. The extensive availability of commercial media and reagent products tailored to specific cell types significantly contributes to this segment's substantial revenue share. Additionally, these products are user-friendly, ready for immediate use, and are offered in serum-free formulations.
The market is divided into four categories based on cell type: Human, Animal, Microbial and Others. The mammalian cells segment claimed the highest revenue share in 2023 and is anticipated to continue its dominance throughout the forecast period. These culture systems are widely preferred for producing complex protein therapeutics due to their relevance in terms of pharmacokinetics and functionality regarding human post-translational modifications. Consequently, the majority of biopharmaceuticals, such as specific interferons, monoclonal antibodies, thrombolytics, and various therapeutic enzymes, are manufactured using these culture systems.
Cell Expansion Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.
Key market players are implementing various initiatives to expand their market presence and stay competitive. They engage in collaborations, partnership models, product development, agreements, and business expansion strategies in untapped regions. In the dynamic landscape of the cell expansion market, diverse strategies are adopted to meet the increasing demands of research, regenerative medicine, and bioprocessing applications. Companies prioritize technological innovations to enhance cell expansion methodologies, emphasizing automation, scalability, and cost-effectiveness. Noteworthy trends include the growing prominence of advanced bioreactor systems, microcarrier-based cultures, and single-use technologies, facilitating efficient large-scale cell production for therapeutic purposes. Furthermore, there is a notable shift toward developing xeno-free and chemically defined culture systems to meet regulatory requirements and ensure reproducibility and safety in expanded cells for clinical applications. Collaborations and partnerships between industry players and research institutions are on the rise, fostering the exchange of expertise and resources to accelerate advancements in cell expansion technologies. Market participants strategically invest in research and development, exploring novel approaches such as 3D cell culture systems and gene editing technologies to address challenges and unlock new opportunities in the expanding field of cell-based therapies.
In April 2022, STEMCELL Technologies Canada and Applied Cells Inc. collaborated to modernize cell separation methods. This involved combining Applied Cells' MARS platform with STEMCELL's EasySep kits, simplifying and automating the process of isolating cells from different samples.
GLOBAL CELL EXPANSION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Thermo Fisher Scientific, Inc.
Corning Incorporated
Merck KGaA
Miltenyi Biotec
BD (Becton, Dickinson and Company)
Terumo BCT, Inc.
Sartorius AG
Takara Bio Inc.
TRINOVA BIOCHEM GmbH
upcyte technologies GmbH
Others